The core infrastructure of the Microbiota Therapeutics Outcomes Program is supported by a University of Toronto Department of Medicine Integrating Challenge Grant.
There are three funded studies currently involved with the MTOP.
1. Long-term Measurement of Multidisciplinary Outcomes in Patients Receiving Fecal Microbiota Transplantation (FMT) in the University of Toronto Microbiota Therapeutics Outcomes Program (MTOP)
Co-Principal Investigators: Susy Hota, Susan M. Poutanen
Funding Agency: Department of Medicine Integrating Challenge Grant Program
Contact person: Satyender Singh, email@example.com / 416-340-4800 ext. 8353
2. Fecal microbiota transplant from healthy lean donors to morbidly obese individuals: effect on insulin resistance and other obesity-related parameters. A randomized controlled trial.
Principal Investigator: Dr. Johane Allard
Funding Agency: CIHR
Description: Our hypothesis is that a fecal transplant from healthy lean donors into morbidly obese subjects will lead to an improvement in glucose metabolism and to a reduction in body weight, appetite, and food intake as well as to an improvement in quality of life, depression and anxiety scores. This is an ongoing study and recruitment is still active.
Contact person: Monica Laura Ponta, firstname.lastname@example.org / 416-340-4413
3. Name of the Study: A Randomized Controlled Trial of the Safety and Efficacy of Fecal Microbiota Transplantation in a Population with Bipolar Disorder
Principal investigator: Dr. Valerie Taylor
Funding Agency: The Stanley Medical Research Institute (SMRI)
Contact person: Asem Bala, email@example.com / 416-351-3732 ext. 2301